Terms: = Skin cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Treatment
5 results:
1. Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer.
Tan X; Zou S; Chen H; Chen D
J Int Med Res; 2023 Sep; 51(9):3000605231200267. PubMed ID: 37756606
[TBL] [Abstract] [Full Text] [Related]
2. Kinetics of he4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Alegría-Baños JA; Jiménez-López JC; Vergara-Castañeda A; de León DFC; Mohar-Betancourt A; Pérez-Montiel D; Sánchez-Domínguez G; García-Villarejo M; Olivares-Pérez C; Hernández-Constantino Á; González-Santiago A; Clara-Altamirano M; Arela-Quispe L; Prada-Ortega D
J Ovarian Res; 2021 Jul; 14(1):96. PubMed ID: 34275472
[TBL] [Abstract] [Full Text] [Related]
3. A strengthening the reporting of observational studies in epidemiology (STROBE): Are he4 and CA 125 suitable to detect a Paget disease of the vulva?
Dellino M; Gargano G; Tinelli R; Carriero C; Minoia C; Tetania S; Silvestris E; Loizzi V; Paradiso A; Casamassima P; Tufaro A; Cormio G; Garrisi VM
Medicine (Baltimore); 2021 Feb; 100(5):e24485. PubMed ID: 33592901
[TBL] [Abstract] [Full Text] [Related]
4. Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than he4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
Abdalla N; Piorkowski R; Bachanek M; Stanirowski P; Cendrowski K; Sawicki W
Dis Markers; 2018; 2018():5289804. PubMed ID: 29849823
[TBL] [Abstract] [Full Text] [Related]
5. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract] [Full Text] [Related]